Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL

• Tingting Zhang,
• Zhenzhen Zhang,
• Xiubao Ren,
• Jin He,
• Zhengzi Qian,
• Bin Meng,
• Lei Jiao,
• Hengqi Liu,
• Lanfang Li,
• Lihua Qiu,
• Shiyong Zhou,
• Wenchen Gong,
• Huilai Zhang,
• Xianhuo Wang

Affiliations

Tingting Zhang

Population Health Sciences, University of Bristol, Bristol, UK

Zhenzhen Zhang

The Jockey Club School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong SAR, China

Xiubao Ren

Aff448 grid.33763.320000000417612484Tianjin University Cancer Institute and Hospital Tianjin Hebei People’s Republic of China

Jin He

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Zhengzi Qian

4Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, the Sino-US Center for Lymphoma and Leukemia Rese, Tianjin, China

Bin Meng

Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Center Prevention and Therapy, Tianjin`s Clinical Research Center for Cancer; and

Lei Jiao

Dermatology, Beijing Children’s Hospital, National Center for Children’s Health, Capital Medical University, Beijing, China

Hengqi Liu

1 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China

Lanfang Li

1 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China

Lihua Qiu

1 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China

Shiyong Zhou

1 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China

Wenchen Gong

4 Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Huilai Zhang

1 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China

Xianhuo Wang

1 Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma and Leukemia Research, Tianjin, China